---
title: "688799.SH (688799.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688799.SH/news.md"
symbol: "688799.SH"
name: "688799.SH"
parent: "https://longbridge.com/en/quote/688799.SH.md"
datetime: "2026-05-21T07:47:53.777Z"
locales:
  - [en](https://longbridge.com/en/quote/688799.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688799.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688799.SH/news.md)
---

# 688799.SH (688799.SH) — Related News

### [](https://longbridge.com/en/news/283423182.md)
*2026-04-21T01:40:16.000Z*
> The A-share pharmaceutical sector was active at the beginning of the trading session, with YIBAI PHARMACEUTICAL hitting 

### [HWPC released its first-quarter performance, with a net profit attributable to the parent company of 26.88 million yuan, a year-on-year decrease of 34.79%](https://longbridge.com/en/news/283362543.md)
*2026-04-20T13:31:08.000Z*
> HWPC released its Q1 2026 earnings report, with revenue of 325 million yuan, a year-on-year decrease of 3.48%; net profi

### [HWPC: The "Drug Registration Certificate" for Fumaric Acid Vorinostat Tablets has been approved](https://longbridge.com/en/news/282318013.md)
*2026-04-10T09:11:51.000Z*
> HWPC announced that the company recently received the Drug Registration Certificate for Fumaric Acid Vonoprazan Tablets 

### [HWPC: The transfer of 8.44% of the company's shares by the controlling shareholder Warner Pharmaceuticals has been completed](https://longbridge.com/en/news/281858024.md)
*2026-04-07T09:35:03.000Z*
> HWPC announced that its controlling shareholder, Warner Pharmaceuticals, has completed the transfer of 8.44% of the comp

### [](https://longbridge.com/en/news/281285803.md)
*2026-04-01T02:07:30.000Z*
> Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, In

### [The concept of innovative drugs strengthened at the beginning of the trading session, with TJPC achieving four consecutive trading limits](https://longbridge.com/en/news/281281113.md)
*2026-04-01T01:35:56.000Z*
> The innovative drug concept strengthened at the beginning of the trading session. As of the time of writing, TJPC has ac

### [HWPC: Controlling shareholder Warner Pharmaceuticals plans to transfer 11,079,600 shares](https://longbridge.com/en/news/280304500.md)
*2026-03-24T11:11:10.000Z*
> HWPC announced that its controlling shareholder, Hunan Warner Pharmaceutical Investment Partnership, intends to transfer